Vista Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$333K Sell
5,786
-55
-0.9% -$3.16K 0.08% 138
2026
Q1
$354K Buy
5,841
+14
+0.2% +$816 0.09% 133
2025
Q4
$314K Buy
5,827
+470
+9% +$22.6K 0.08% 136
2025
Q3
$242K Buy
5,357
+11
+0.2% +$514 0.07% 145
2025
Q2
$247K Sell
5,346
-56
-1% -$2.75K 0.07% 141
2025
Q1
$329K Buy
5,402
+157
+3% +$9.15K 0.1% 133
2024
Q4
$297K Sell
5,245
-294
-5% -$16.4K 0.09% 135
2024
Q3
$287K Buy
5,539
+10
+0.2% +$469 0.09% 129
2024
Q2
$230K Sell
5,529
-23,443
-81% -$1.05M 0.08% 141
2024
Q1
$1.57M Sell
28,972
-724
-2% -$36.9K 0.53% 57
2023
Q4
$1.52M Buy
+29,696
New +$1.56M 0.56% 57

Other funds holding BMY

Vista Investment Partners's BMY Position: Q2 2026 in Review

Vista Investment Partners reduced its Bristol-Myers Squibb (BMY) stake by 0.94% in Q2 2026, selling an estimated $3.16K and leaving 5,786 shares worth $333K. The position accounts for 0.08% of the portfolio, ranked #138.

Vista Investment Partners first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.57M in Q1 2024. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Vista Investment Partners held 5,786 shares of Bristol-Myers Squibb worth $333K as of Q2 2026.
  • Vista Investment Partners sold 55 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.16K.
  • Bristol-Myers Squibb made up 0.08% of Vista Investment Partners's portfolio in Q2 2026, its #138 holding.
  • Vista Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • Vista Investment Partners's Bristol-Myers Squibb position peaked at $1.57M in Q1 2024.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Vista Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.